Loading [a11y]/accessibility-menu.js
Review
BibTex RIS Cite

Kardiyovasküler Hastalıklarda Gebelik, Doğum ve Doğum Sonu Dönem

Year 2024, Volume: 9 Issue: 3, 385 - 392, 31.12.2024

Hülya Ulaşlı , Hüsniye Dinç Kaya , Sevil Günaydın , Tülay Yılmaz

https://doi.org/10.51754/cusbed.1515917

Abstract

Gebelikte kardiyovasküler hastalıklar dolaylı anne ölümlerinin başlıca nedenidir. İlerleyen gebelik yaşı, obezite, sedanter yaşam tarzı ve değişen beslenme alışkanlıkları gibi faktörler kardiyovasküler sistem hastalıklarına bağlı anne ölüm oranlarında artmaya sebep olmaktadır. Gebelik sırasında ayrıntılı öykü alma ve fizik muayene ile kardiyovasküler risk değerlendirmesi yapılmalıdır. Bu doğrultuda gebenin kalp hastalıkları sınıflandırma sistemine göre derecesi ve saptanan kalp rahatsızlıkları doğrultusunda gebeliği ve doğumu planlanmalıdır. Kalp hastası kadınların mutlaka hastane ortamında doğum yapması sağlanmalıdır. Deneyimli bir sağlık ekibi tarafından doğum şekli ve doğum yerine karar verilmelidir. Doğum multidisipliner yaklaşım uygulanabilecek bir merkezde yapılmalıdır. Bireysel doğum planıyla birlikte genellikle vajinal doğum tercih edilebilir. Kadının kullandığı aldığı ilaçlar, doğum sonu ve laktasyon sürecinde de güvenlik açısından değerlendirilmelidir. Bu derlemenin amacı gebelik, doğum ve doğum sonu dönemde kardiyovasküler hastalıkları literatür doğrultusunda irdelemektir.

Keywords

Gebelik doğum doğum sonu dönem kardiyovasküler hastalıklar

Ethical Statement

Derleme yazısı olması nedeniyle etik kurul izni bulunmamaktadır.

Supporting Institution

-

Project Number

-

Thanks

-

References

  • ACOG Practice Bulletin No. 212 (2019): Pregnancy and heart disease. Obstetrics & Gynecology, 133(5), e320-e356. https://doi.org/10.1097/AOG.0000000000003243
  • Balci, A., Sollie-Szarynska, K. M., van der Bijl, A. G., Ruys, T. P., Mulder, B. J., Roos-Hesselink, J. W., ... & Pieper, P. G. (2014). Prospective validation and assessment of cardiovascular and offspring risk models for pregnant women with congenital heart disease. Heart, 100(17), 1373-1381. https://doi.org/10.1136/heartjnl-2014-305597
  • Beaton, A., Okello, E., Scheel, A., DeWyer, A., Ssembatya, R., Baaka, O., ... & Sable, C. (2019). Impact of heart disease on maternal, fetal and neonatal outcomes in a low-resource setting. Heart, 105(10), 755-760. https://doi.org/10.1136/heartjnl-2018-313810
  • Bennett, J. A., Riegel, B., Bittner, V., & Nichols, J. (2002). Validity and reliability of the NYHA classes for measuring research outcomes in patients with cardiac disease. Heart & Lung, 31(4), 262-270. https://doi.org/10.1067/mhl.2002.124554
  • Bredy, C., Deville, F., Huguet, H., Picot, M. C., De La Villeon, G., Abassi, H., ... & Amedro, P. (2023). Which risk score best predicts cardiovascular outcome in pregnant women with congenital heart disease?. European Heart Journal-Quality of Care and Clinical Outcomes, 9(2), 177-183. https://doi.org/10.1093/ehjqcco/qcac019
  • Bright, R. A., Lima, F. V., Avila, C., Butler, J., & Stergiopoulos, K. (2021). Maternal Heart Failure. Journal of the American Heart Association, 10(14), e021019. https://doi.org/10.1161/JAHA.121.021019
  • Canobbio, M. M., Warnes, C. A., Aboulhosn, J., Connolly, H. M., Khanna, A., Koos, B. J., ... & Stout, K. (2017). Management of pregnancy in patients with complex congenital heart disease: a scientific statement for healthcare professionals from the American Heart Association. Circulation, 135(8), e50-e87. https://doi.org/10.1161/CIR.0000000000000458
  • Coffey, S., Roberts-Thomson, R., Brown, A., Carapetis, J., Chen, M., Enriquez-Sarano, M., ... & Prendergast, B. D. (2021). Global epidemiology of valvular heart disease. Nature Reviews Cardiology, 18(12), 853-864. https://doi.org/10.1038/s41569-021-00570-z
  • Davutoğlu, E., Yüksel, M. A., Öncül, M., Şükrü, Ç. E. B. İ., & Madazlı, R. (2015). Kalp hastalığı ve gebelik: Maternal ve fetal sonuçlar. Journal Of Clinical Obstetrics & Gynecology, 25(2), 103-110. https://doi.org/10.5336/gynobstet.2014-43155
  • Drenthen, W., Pieper, P. G., Roos-Hesselink, J. W., van Lottum, W. A., Voors, A. A., Mulder, B. J., ... & Zahara Investigators. (2007). Outcome of pregnancy in women with congenital heart disease: a literature review. Journal of the American College of Cardiology, 49(24), 2303-2311. https://doi.org/10.1016/j.jacc.2007.03.027
  • Ducas, R. A., Javier, D. A., D’Souza, R., Silversides, C. K., & Tsang, W. (2020). Pregnancy outcomes in women with significant valve disease: A systematic review and meta-analysis. Heart, 106(7), 512-519. https://doi.org/10.1136/heartjnl-2019-315859
  • Eggleton, E. J., Bhagra, C. J., Patient, C. J., Belham, M., Pickett, J., & Aiken, C. E. (2023). Maternal left ventricular function and adverse neonatal outcomes in women with cardiac disease. Archives of Gynecology and Obstetrics, 307(5), 1431-1439. https://doi.org/10.1007/s00404-022-06635-9
  • Eggleton, E. J., Mcmurrugh, K. J., & Aiken, C. E. (2022). Perinatal outcomes in pregnancies complicated by maternal cardiomyopathy: A systematic review and meta-analysis. American Journal of Obstetrics and Gynecology, 228(3), 283-291. https://doi.org/10.1016/j.ajog.2022.09.025
  • Giussani, D. A. (2021). Breath of life: Heart disease link to developmental hypoxia. Circulation, 144(17), 1429-1443. https://doi.org/10.1161/CIRCULATIONAHA.121.054689
  • Halpern, D. G., Weinberg, C. R., Pinnelas, R., Mehta-Lee, S., Economy, K. E., & Valente, A. M. (2019). Use of medication for cardiovascular disease during pregnancy: JACC state-of-the-art review. Journal of the American College of Cardiology, 73(4), 457-476. https://doi.org/10.1016/j.jacc.2018.10.075
  • Hardee, I., Wright, L., McCracken, C., Lawson, E., & Oster, M. E. (2021). Maternal and neonatal outcomes of pregnancies in women with congenital heart disease: a meta‐analysis. Journal of the American Heart Association, 10(8), e017834. https://doi.org/10.1161/JAHA.120.017834
  • Hilfiker-Kleiner, D., Haghikia, A., Nonhoff, J., & Bauersachs, J. (2015). Peripartum cardiomyopathy: current management and future perspectives. European Heart Journal, 36(18), 1090-1097. https://doi.org/10.1093/eurheartj/ehv009
  • https://data.unicef.org/topic/maternal-health/maternal-mortality/ Accessed 26 June 2024
  • https://www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds) Accessed 05 July 2024
  • Kılıç, A., Çalım, S.İ. (2020). Kardiyovasküler Bozukluklar ve Gebelik. (Ed. Emel Taşçı Turan ve Emine Gerçek). Yüksek Riskli gebelikler ve Yönetimi. Nobel Akademik Yayıncılık. s.351-352.
  • Kızılırmak, A., Nacar, G., & Timur Taşhan, S. (2022). Doğum, Kadın Sağlığı ve Hastalıkları Hemşireliği. İçinde N.Evşen (Ed.), Gebeliği etkileyen sağlık durumları. (s.272). Akademisyen Kitabevi. https://doi.org/10.37609/akya.1183
  • Kotit, S., & Yacoub, M. (2021). Cardiovascular adverse events in pregnancy: A global perspective. Global Cardiology Science & Practice, 2021(1). https://doi.org/10.21542/gcsp.2021.5
  • Koutrolou-Sotiropoulou, P., Parikh, P. B., Miller, C., Lima, F. V., Butler, J., & Stergiopoulos, K. (2015). Impact of heart disease on maternal and fetal outcomes in pregnant women. The American Journal of Cardiology, 116(3), 474-480. https://doi.org/10.1016/j.amjcard.2015.04.063
  • Lewey, J., Andrade, L., & Levine, L. D. (2021). Valvular heart disease in pregnancy. Cardiology Clinics, 39(1), 151-161. https://doi.org/10.1016/j.ccl.2020.09.010.
  • Lima, F. V., Yang, J., Xu, J., & Stergiopoulos, K. (2017). National trends and in-hospital outcomes in pregnant women with heart disease in the United States. The American Journal of Cardiology, 119(10), 1694-1700. https://doi.org/10.1016/j.amjcard.2017.02.003
  • Madazlı, R. (2021). Gebelik ve Sistemik Hastalıklar. İçinde Rıza Madazlı (Ed.) Kalp Hastalıkları. (s. 6). İstanbul Tıp Kitabevleri.
  • McKenna, W. J., Maron, B. J., & Thiene, G. (2017). Classification, epidemiology, and global burden of cardiomyopathies. Circulation Research, 121(7), 722-730. https://doi.org/10.1161/CIRCRESAHA.117.309711
  • Mehta, L. S., Warnes, C. A., Bradley, E., Burton, T., Economy, K., Mehran, R., ... & American Heart Association Council on Clinical Cardiology; Council on Arteriosclerosis, Thrombosis and Vascular Biology; Council on Cardiovascular and Stroke Nursing; and Stroke Council. (2020). Cardiovascular considerations in caring for pregnant patients: a scientific statement from the American Heart Association. Circulation, 141(23), e884-e903. https://doi.org/10.1161/CIR.0000000000000772
  • Nguyen Manh, T., Bui Van, N., Le Thi, H., Vo Hoang, L., Nguyen Si Anh, H., Trinh Thi Thu, H., Nguyen Xuan, T., et al. (2019). Pregnancy with Heart Disease: Maternal Outcomes and Risk Factors for Fetal Growth Restriction. International Journal of Environmental Research and Public Health, 16(12), 2075. https://doi.org/10.3390/ijerph16122075
  • Owens, A., Yang, J., Nie, L., Lima, F., Avila, C., & Stergiopoulos, K. (2018). Neonatal and maternal outcomes in pregnant women with cardiac disease. Journal of the American Heart Association, 7(21), e009395. https://doi.org/10.1161/JAHA.118.009395
  • Parikh, N. I., Gonzalez, J. M., Anderson, C. A., Judd, S. E., Rexrode, K. M., Hlatky, M. A., ... & American Heart Association Council on Epidemiology and Prevention; Council on Arteriosclerosis, Thrombosis and Vascular Biology; Council on Cardiovascular and Stroke Nursing; and the Stroke Council. (2021). Adverse pregnancy outcomes and cardiovascular disease risk: unique opportunities for cardiovascular disease prevention in women: a scientific statement from the American Heart Association. Circulation, 143(18), e902-e916. https://doi.org/10.1161/CIR.0000000000000961
  • Pearson, G. J., Thanassoulis, G., Anderson, T. J., Barry, A. R., Couture, P., Dayan, N., ... & Wray, W. (2021). 2021 Canadian Cardiovascular Society guidelines for the management of dyslipidemia for the prevention of cardiovascular disease in adults. Canadian Journal of Cardiology, 37(8), 1129-1150. https://doi.org/10.1016/j.cjca.2021.03.016
  • Pfaller, B., Sathananthan, G., Grewal, J., Mason, J., D’Souza, R., Spears, D., ... & Silversides, C. K. (2020). Preventing complications in pregnant women with cardiac disease. Journal of the American College of Cardiology, 75(12), 1443-1452. https://doi.org/10.1016/j.jacc.2020.01.039
  • Pijuan-Domenech, A., Galian, L., Goya, M., Casellas, M., Merced, C., Ferreira-Gonzalez, I., ... & Garcia-Dorado, D. (2015). Cardiac complications during pregnancy are better predicted with the modified WHO risk score. International Journal of Cardiology, 195, 149-154. https://doi.org/10.1016/j.ijcard.2015.05.076
  • Ramlakhan, K. P., Johnson, M. R., & Roos-Hesselink, J. W. (2020). Pregnancy and cardiovascular disease. Nature Reviews Cardiology, 17(11), 718-731. https://doi.org/10.1038/s41569-020-0390-z
  • Regitz-Zagrosek, V., Roos-Hesselink, J. W., Bauersachs, J., Blomström-Lundqvist, C., Cifkova, R., De Bonis, M., ... & Warnes, C. A. (2018). 2018 ESC guidelines for the management of cardiovascular diseases during pregnancy: the task force for the management of cardiovascular diseases during pregnancy of the European Society of Cardiology (ESC). European Heart Journal, 39(34), 3165-3241. https://doi.org/10.1093/eurheartj/ehy340
  • Roos-Hesselink, J., Baris, L., Johnson, M., De Backer, J., Otto, C., Marelli, A., ... & Hall, R. (2019). Pregnancy outcomes in women with cardiovascular disease: evolving trends over 10 years in the ESC Registry Of Pregnancy And Cardiac disease (ROPAC). European Heart Journal, 40(47), 3848-3855. https://doi.org/10.1093/eurheartj/ehz136
  • Sanghavi, M., & Rutherford, J. D. (2014). Cardiovascular physiology of pregnancy. Circulation, 130(12), 1003-1008. https://doi.org/10.1161/CIRCULATIONAHA.114.009029
  • Say, L., Chou, D., Gemmill, A., Tunçalp, Ö., Moller, A. B., Daniels, J., Gülmezoğlu, A.M., Temmerman, M. Et Alkema, L. (2014). Global causes of maternal death: a WHO systematic analysis. The Lancet Global Health, 2(6), e323-e333. https://doi.org/10.1016/S2214-109X(14)70227-X
  • Schaufelberger, M. (2019). Cardiomyopathy and pregnancy. Heart, 105(20), 1543-1551. https://doi.org/10.1136/heartjnl-2018-313476
  • Sehgal, A., Skilton, M. R., & Crispi, F. (2016). Human fetal growth restriction: a cardiovascular journey through to adolescence. Journal of Developmental Origins of Health and Disease, 7(6), 626-635. https://doi.org/10.1017/S2040174416000337
  • Silversides, C. K., Grewal, J., Mason, J., Sermer, M., Kiess, M., Rychel, V., ... & Siu, S. C. (2018). Pregnancy outcomes in women with heart disease: the CARPREG II study. Journal of the American College of Cardiology, 71(21), 2419-2430. https://doi.org/10.1016/j.jacc.2018.02.076
  • Storm, F., Agampodi, S., Eddleston, M., Sørensen, J. B., Konradsen, F., & Rheinländer, T. (2014). Indirect causes of maternal death. The Lancet Global Health, 2(10), e566. https://doi.org/10.1016/S2214-109X(14)70297-9 Türkiye Anne Ölümleri Raporu (2015-2019) T.C. Sağlık Bakanlığı Halk Sağlığı Genel Müdürlüğü, 1208, Ankara, 2021.
  • van Hagen, I. M., & Roos-Hesselink, J. W. (2020). Pregnancy in congenital heart disease: risk prediction and counselling. Heart, 106(23), 1853-1861. https://doi.org/10.1136/heartjnl-2019-314702
  • van Hagen, I. M., Boersma, E., Johnson, M. R., Thorne, S. A., Parsonage, W. A., Escribano Subias, P., ... & ROPAC investigators and EORP team. (2016). Global cardiac risk assessment in the Registry Of Pregnancy And Cardiac disease: results of a registry from the European Society of Cardiology. European Journal of Heart Failure, 18(5), 523-533. https://doi.org/10.1002/ejhf.501
  • van Hagen, I. M., Thorne, S. A., Taha, N., Youssef, G., Elnagar, A., Gabriel, H., ... & Roos-Hesselink, J. W. (2018). Pregnancy outcomes in women with rheumatic mitral valve disease: results from the registry of pregnancy and cardiac disease. Circulation, 137(8), 806-816. https://doi.org/10.1161/CIRCULATIONAHA.117.032561
  • Warnes, C. A. (2015). Pregnancy and delivery in women with congenital heart disease. Circulation Journal, 79(7), 1416-1421. https://doi.org/10.1253/circj.CJ-15-0572
  • World Health Organization. (2019). Trends in maternal mortality 2000 to 2017: estimates by WHO, UNICEF, UNFPA, World Bank Group and the United Nations Population Division.
  • Yüksekol, D., Mucuk, M. (2019). Riskli gebelikler ve bakım. İçinde S. T. Taşhan, Ö. D. Yüksekol ve M.Duman (Ed.), Gebelikte Kardiyovasküler Sistem Hastalıkları ve Bakım (s. 274) Göktuğ Yayıncılık.

Pregnancy, Childbirth, and Postpartum Period in Cardiovascular Diseases

Year 2024, Volume: 9 Issue: 3, 385 - 392, 31.12.2024

Hülya Ulaşlı , Hüsniye Dinç Kaya , Sevil Günaydın , Tülay Yılmaz

https://doi.org/10.51754/cusbed.1515917

Abstract

Cardiovascular diseases during pregnancy are the primary cause of indirect maternal deaths. Factors such as advancing maternal age, obesity, sedentary lifestyle, and changing dietary habits contribute to the increased maternal mortality rates associated with cardiovascular diseases. Comprehensive history taking and physical examination should be conducted during pregnancy to assess cardiovascular risk. Accordingly, the pregnancy and delivery should be planned based on the classification of the mother's heart disease and any identified cardiac conditions. Women with heart disease must deliver in a hospital setting. The mode and place of delivery should be determined by an experienced healthcare team. Delivery should occur in a center where a multidisciplinary approach can be implemented. While an individualized birth plan should be developed, vaginal delivery is generally preferred. Medications used by the woman should be evaluated for safety during the postpartum and lactation periods. This review aims to examine cardiovascular diseases during pregnancy, delivery, and the postpartum period in light of the literature.

Keywords

Childbirth Postpartum Period Cardiovascular diseases

Project Number

-

References

  • ACOG Practice Bulletin No. 212 (2019): Pregnancy and heart disease. Obstetrics & Gynecology, 133(5), e320-e356. https://doi.org/10.1097/AOG.0000000000003243
  • Balci, A., Sollie-Szarynska, K. M., van der Bijl, A. G., Ruys, T. P., Mulder, B. J., Roos-Hesselink, J. W., ... & Pieper, P. G. (2014). Prospective validation and assessment of cardiovascular and offspring risk models for pregnant women with congenital heart disease. Heart, 100(17), 1373-1381. https://doi.org/10.1136/heartjnl-2014-305597
  • Beaton, A., Okello, E., Scheel, A., DeWyer, A., Ssembatya, R., Baaka, O., ... & Sable, C. (2019). Impact of heart disease on maternal, fetal and neonatal outcomes in a low-resource setting. Heart, 105(10), 755-760. https://doi.org/10.1136/heartjnl-2018-313810
  • Bennett, J. A., Riegel, B., Bittner, V., & Nichols, J. (2002). Validity and reliability of the NYHA classes for measuring research outcomes in patients with cardiac disease. Heart & Lung, 31(4), 262-270. https://doi.org/10.1067/mhl.2002.124554
  • Bredy, C., Deville, F., Huguet, H., Picot, M. C., De La Villeon, G., Abassi, H., ... & Amedro, P. (2023). Which risk score best predicts cardiovascular outcome in pregnant women with congenital heart disease?. European Heart Journal-Quality of Care and Clinical Outcomes, 9(2), 177-183. https://doi.org/10.1093/ehjqcco/qcac019
  • Bright, R. A., Lima, F. V., Avila, C., Butler, J., & Stergiopoulos, K. (2021). Maternal Heart Failure. Journal of the American Heart Association, 10(14), e021019. https://doi.org/10.1161/JAHA.121.021019
  • Canobbio, M. M., Warnes, C. A., Aboulhosn, J., Connolly, H. M., Khanna, A., Koos, B. J., ... & Stout, K. (2017). Management of pregnancy in patients with complex congenital heart disease: a scientific statement for healthcare professionals from the American Heart Association. Circulation, 135(8), e50-e87. https://doi.org/10.1161/CIR.0000000000000458
  • Coffey, S., Roberts-Thomson, R., Brown, A., Carapetis, J., Chen, M., Enriquez-Sarano, M., ... & Prendergast, B. D. (2021). Global epidemiology of valvular heart disease. Nature Reviews Cardiology, 18(12), 853-864. https://doi.org/10.1038/s41569-021-00570-z
  • Davutoğlu, E., Yüksel, M. A., Öncül, M., Şükrü, Ç. E. B. İ., & Madazlı, R. (2015). Kalp hastalığı ve gebelik: Maternal ve fetal sonuçlar. Journal Of Clinical Obstetrics & Gynecology, 25(2), 103-110. https://doi.org/10.5336/gynobstet.2014-43155
  • Drenthen, W., Pieper, P. G., Roos-Hesselink, J. W., van Lottum, W. A., Voors, A. A., Mulder, B. J., ... & Zahara Investigators. (2007). Outcome of pregnancy in women with congenital heart disease: a literature review. Journal of the American College of Cardiology, 49(24), 2303-2311. https://doi.org/10.1016/j.jacc.2007.03.027
  • Ducas, R. A., Javier, D. A., D’Souza, R., Silversides, C. K., & Tsang, W. (2020). Pregnancy outcomes in women with significant valve disease: A systematic review and meta-analysis. Heart, 106(7), 512-519. https://doi.org/10.1136/heartjnl-2019-315859
  • Eggleton, E. J., Bhagra, C. J., Patient, C. J., Belham, M., Pickett, J., & Aiken, C. E. (2023). Maternal left ventricular function and adverse neonatal outcomes in women with cardiac disease. Archives of Gynecology and Obstetrics, 307(5), 1431-1439. https://doi.org/10.1007/s00404-022-06635-9
  • Eggleton, E. J., Mcmurrugh, K. J., & Aiken, C. E. (2022). Perinatal outcomes in pregnancies complicated by maternal cardiomyopathy: A systematic review and meta-analysis. American Journal of Obstetrics and Gynecology, 228(3), 283-291. https://doi.org/10.1016/j.ajog.2022.09.025
  • Giussani, D. A. (2021). Breath of life: Heart disease link to developmental hypoxia. Circulation, 144(17), 1429-1443. https://doi.org/10.1161/CIRCULATIONAHA.121.054689
  • Halpern, D. G., Weinberg, C. R., Pinnelas, R., Mehta-Lee, S., Economy, K. E., & Valente, A. M. (2019). Use of medication for cardiovascular disease during pregnancy: JACC state-of-the-art review. Journal of the American College of Cardiology, 73(4), 457-476. https://doi.org/10.1016/j.jacc.2018.10.075
  • Hardee, I., Wright, L., McCracken, C., Lawson, E., & Oster, M. E. (2021). Maternal and neonatal outcomes of pregnancies in women with congenital heart disease: a meta‐analysis. Journal of the American Heart Association, 10(8), e017834. https://doi.org/10.1161/JAHA.120.017834
  • Hilfiker-Kleiner, D., Haghikia, A., Nonhoff, J., & Bauersachs, J. (2015). Peripartum cardiomyopathy: current management and future perspectives. European Heart Journal, 36(18), 1090-1097. https://doi.org/10.1093/eurheartj/ehv009
  • https://data.unicef.org/topic/maternal-health/maternal-mortality/ Accessed 26 June 2024
  • https://www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds) Accessed 05 July 2024
  • Kılıç, A., Çalım, S.İ. (2020). Kardiyovasküler Bozukluklar ve Gebelik. (Ed. Emel Taşçı Turan ve Emine Gerçek). Yüksek Riskli gebelikler ve Yönetimi. Nobel Akademik Yayıncılık. s.351-352.
  • Kızılırmak, A., Nacar, G., & Timur Taşhan, S. (2022). Doğum, Kadın Sağlığı ve Hastalıkları Hemşireliği. İçinde N.Evşen (Ed.), Gebeliği etkileyen sağlık durumları. (s.272). Akademisyen Kitabevi. https://doi.org/10.37609/akya.1183
  • Kotit, S., & Yacoub, M. (2021). Cardiovascular adverse events in pregnancy: A global perspective. Global Cardiology Science & Practice, 2021(1). https://doi.org/10.21542/gcsp.2021.5
  • Koutrolou-Sotiropoulou, P., Parikh, P. B., Miller, C., Lima, F. V., Butler, J., & Stergiopoulos, K. (2015). Impact of heart disease on maternal and fetal outcomes in pregnant women. The American Journal of Cardiology, 116(3), 474-480. https://doi.org/10.1016/j.amjcard.2015.04.063
  • Lewey, J., Andrade, L., & Levine, L. D. (2021). Valvular heart disease in pregnancy. Cardiology Clinics, 39(1), 151-161. https://doi.org/10.1016/j.ccl.2020.09.010.
  • Lima, F. V., Yang, J., Xu, J., & Stergiopoulos, K. (2017). National trends and in-hospital outcomes in pregnant women with heart disease in the United States. The American Journal of Cardiology, 119(10), 1694-1700. https://doi.org/10.1016/j.amjcard.2017.02.003
  • Madazlı, R. (2021). Gebelik ve Sistemik Hastalıklar. İçinde Rıza Madazlı (Ed.) Kalp Hastalıkları. (s. 6). İstanbul Tıp Kitabevleri.
  • McKenna, W. J., Maron, B. J., & Thiene, G. (2017). Classification, epidemiology, and global burden of cardiomyopathies. Circulation Research, 121(7), 722-730. https://doi.org/10.1161/CIRCRESAHA.117.309711
  • Mehta, L. S., Warnes, C. A., Bradley, E., Burton, T., Economy, K., Mehran, R., ... & American Heart Association Council on Clinical Cardiology; Council on Arteriosclerosis, Thrombosis and Vascular Biology; Council on Cardiovascular and Stroke Nursing; and Stroke Council. (2020). Cardiovascular considerations in caring for pregnant patients: a scientific statement from the American Heart Association. Circulation, 141(23), e884-e903. https://doi.org/10.1161/CIR.0000000000000772
  • Nguyen Manh, T., Bui Van, N., Le Thi, H., Vo Hoang, L., Nguyen Si Anh, H., Trinh Thi Thu, H., Nguyen Xuan, T., et al. (2019). Pregnancy with Heart Disease: Maternal Outcomes and Risk Factors for Fetal Growth Restriction. International Journal of Environmental Research and Public Health, 16(12), 2075. https://doi.org/10.3390/ijerph16122075
  • Owens, A., Yang, J., Nie, L., Lima, F., Avila, C., & Stergiopoulos, K. (2018). Neonatal and maternal outcomes in pregnant women with cardiac disease. Journal of the American Heart Association, 7(21), e009395. https://doi.org/10.1161/JAHA.118.009395
  • Parikh, N. I., Gonzalez, J. M., Anderson, C. A., Judd, S. E., Rexrode, K. M., Hlatky, M. A., ... & American Heart Association Council on Epidemiology and Prevention; Council on Arteriosclerosis, Thrombosis and Vascular Biology; Council on Cardiovascular and Stroke Nursing; and the Stroke Council. (2021). Adverse pregnancy outcomes and cardiovascular disease risk: unique opportunities for cardiovascular disease prevention in women: a scientific statement from the American Heart Association. Circulation, 143(18), e902-e916. https://doi.org/10.1161/CIR.0000000000000961
  • Pearson, G. J., Thanassoulis, G., Anderson, T. J., Barry, A. R., Couture, P., Dayan, N., ... & Wray, W. (2021). 2021 Canadian Cardiovascular Society guidelines for the management of dyslipidemia for the prevention of cardiovascular disease in adults. Canadian Journal of Cardiology, 37(8), 1129-1150. https://doi.org/10.1016/j.cjca.2021.03.016
  • Pfaller, B., Sathananthan, G., Grewal, J., Mason, J., D’Souza, R., Spears, D., ... & Silversides, C. K. (2020). Preventing complications in pregnant women with cardiac disease. Journal of the American College of Cardiology, 75(12), 1443-1452. https://doi.org/10.1016/j.jacc.2020.01.039
  • Pijuan-Domenech, A., Galian, L., Goya, M., Casellas, M., Merced, C., Ferreira-Gonzalez, I., ... & Garcia-Dorado, D. (2015). Cardiac complications during pregnancy are better predicted with the modified WHO risk score. International Journal of Cardiology, 195, 149-154. https://doi.org/10.1016/j.ijcard.2015.05.076
  • Ramlakhan, K. P., Johnson, M. R., & Roos-Hesselink, J. W. (2020). Pregnancy and cardiovascular disease. Nature Reviews Cardiology, 17(11), 718-731. https://doi.org/10.1038/s41569-020-0390-z
  • Regitz-Zagrosek, V., Roos-Hesselink, J. W., Bauersachs, J., Blomström-Lundqvist, C., Cifkova, R., De Bonis, M., ... & Warnes, C. A. (2018). 2018 ESC guidelines for the management of cardiovascular diseases during pregnancy: the task force for the management of cardiovascular diseases during pregnancy of the European Society of Cardiology (ESC). European Heart Journal, 39(34), 3165-3241. https://doi.org/10.1093/eurheartj/ehy340
  • Roos-Hesselink, J., Baris, L., Johnson, M., De Backer, J., Otto, C., Marelli, A., ... & Hall, R. (2019). Pregnancy outcomes in women with cardiovascular disease: evolving trends over 10 years in the ESC Registry Of Pregnancy And Cardiac disease (ROPAC). European Heart Journal, 40(47), 3848-3855. https://doi.org/10.1093/eurheartj/ehz136
  • Sanghavi, M., & Rutherford, J. D. (2014). Cardiovascular physiology of pregnancy. Circulation, 130(12), 1003-1008. https://doi.org/10.1161/CIRCULATIONAHA.114.009029
  • Say, L., Chou, D., Gemmill, A., Tunçalp, Ö., Moller, A. B., Daniels, J., Gülmezoğlu, A.M., Temmerman, M. Et Alkema, L. (2014). Global causes of maternal death: a WHO systematic analysis. The Lancet Global Health, 2(6), e323-e333. https://doi.org/10.1016/S2214-109X(14)70227-X
  • Schaufelberger, M. (2019). Cardiomyopathy and pregnancy. Heart, 105(20), 1543-1551. https://doi.org/10.1136/heartjnl-2018-313476
  • Sehgal, A., Skilton, M. R., & Crispi, F. (2016). Human fetal growth restriction: a cardiovascular journey through to adolescence. Journal of Developmental Origins of Health and Disease, 7(6), 626-635. https://doi.org/10.1017/S2040174416000337
  • Silversides, C. K., Grewal, J., Mason, J., Sermer, M., Kiess, M., Rychel, V., ... & Siu, S. C. (2018). Pregnancy outcomes in women with heart disease: the CARPREG II study. Journal of the American College of Cardiology, 71(21), 2419-2430. https://doi.org/10.1016/j.jacc.2018.02.076
  • Storm, F., Agampodi, S., Eddleston, M., Sørensen, J. B., Konradsen, F., & Rheinländer, T. (2014). Indirect causes of maternal death. The Lancet Global Health, 2(10), e566. https://doi.org/10.1016/S2214-109X(14)70297-9 Türkiye Anne Ölümleri Raporu (2015-2019) T.C. Sağlık Bakanlığı Halk Sağlığı Genel Müdürlüğü, 1208, Ankara, 2021.
  • van Hagen, I. M., & Roos-Hesselink, J. W. (2020). Pregnancy in congenital heart disease: risk prediction and counselling. Heart, 106(23), 1853-1861. https://doi.org/10.1136/heartjnl-2019-314702
  • van Hagen, I. M., Boersma, E., Johnson, M. R., Thorne, S. A., Parsonage, W. A., Escribano Subias, P., ... & ROPAC investigators and EORP team. (2016). Global cardiac risk assessment in the Registry Of Pregnancy And Cardiac disease: results of a registry from the European Society of Cardiology. European Journal of Heart Failure, 18(5), 523-533. https://doi.org/10.1002/ejhf.501
  • van Hagen, I. M., Thorne, S. A., Taha, N., Youssef, G., Elnagar, A., Gabriel, H., ... & Roos-Hesselink, J. W. (2018). Pregnancy outcomes in women with rheumatic mitral valve disease: results from the registry of pregnancy and cardiac disease. Circulation, 137(8), 806-816. https://doi.org/10.1161/CIRCULATIONAHA.117.032561
  • Warnes, C. A. (2015). Pregnancy and delivery in women with congenital heart disease. Circulation Journal, 79(7), 1416-1421. https://doi.org/10.1253/circj.CJ-15-0572
  • World Health Organization. (2019). Trends in maternal mortality 2000 to 2017: estimates by WHO, UNICEF, UNFPA, World Bank Group and the United Nations Population Division.
  • Yüksekol, D., Mucuk, M. (2019). Riskli gebelikler ve bakım. İçinde S. T. Taşhan, Ö. D. Yüksekol ve M.Duman (Ed.), Gebelikte Kardiyovasküler Sistem Hastalıkları ve Bakım (s. 274) Göktuğ Yayıncılık.
There are 49 citations in total.

Details

Primary Language Turkish
Subjects Health Services and Systems (Other)
Journal Section Review
Authors

Hülya Ulaşlı 0000-0001-5024-7413

Hüsniye Dinç Kaya 0000-0002-8461-643X

Sevil Günaydın 0000-0003-2539-8783

Tülay Yılmaz 0000-0002-3706-3844

Project Number -
Early Pub Date December 29, 2024
Publication Date December 31, 2024
Submission Date July 13, 2024
Acceptance Date September 5, 2024
Published in Issue Year 2024Volume: 9 Issue: 3

Cite

Vancouver Ulaşlı H, Dinç Kaya H, Günaydın S, Yılmaz T. Kardiyovasküler Hastalıklarda Gebelik, Doğum ve Doğum Sonu Dönem. J Cumhuriyet Univ Health Sci Inst. 2024;9(3):385-92.
 Download Cover Image

The Journal of Sivas Cumhuriyet University Institute of Health Sciences is an international, peer-reviewed scientific journal published by Sivas Cumhuriyet University, Institute of Health Sciences.